Pfizer is undergoing a transformative journey in updating MES to enhance operational efficiency and agility. This shift requires rethinking our current MES operating models to enable rapid scaling and adaptability. By leveraging advanced technologies as data analytics etc, we are in the process of streamlining manufacturing processes, increasing delivery throughput, reducing costs, and meeting regulatory requirements more effectively around the globe. The key to success lies in embracing a holistic approach that integrates MES into the overall digital transformation strategy. This session will discuss:
- What are the Cost Savings and the Effiiencies gained?
- How did we achieve a 4 times increase in delivery throughput?
- What are the strategies to now complete the rest of our supply network in the next 4 years? What is the MES deployment roadmap?.
- How did we achieve a 70% decrease in costs per Electronic Batch Record?
- Why is it so important to follow a value based driven approach for the customers?
- Measuring before and after the transformation: How far could we reduce the cycle time?
- How to drive the IT/OT Convergence?
&nsbp;
